drugset / Trial / NCT00103714
Study of Denufosol Tetrasodium in Patients With Cystic Fibrosis Lung Disease
RandomizedParallel-groupDouble-blindTreatment
Summary
The objectives of this study are to evaluate the safety, tolerability and preliminary efficacy of two dose levels of INS37217 (denufosol tetrasodium) Inhalation Solution in patients with cystic fibrosis (CF) lung disease.
Timeline
- Start
- 2005-01
- Primary completion
- 2005-08
- Completion
- 2005-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | denufosol | Other / unclassified | — | Inhaled |